These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2773899)

  • 21. Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis.
    Veereman Wauters G; Ferrell L; Ostroff JW; Heyman MB
    Am J Gastroenterol; 1990 Oct; 85(10):1395-7. PubMed ID: 2220735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Eradication of Helicobacter pylori in patients with recurrent abdominal pain using a triple drug treatment].
    Ramírez Mayans J; Zamora Dávila E; Cervantes Bustamante R; Mata Rivera N; Oyervides García CI; Cuevas Schacht F; Sosa de Martínez MC
    Rev Gastroenterol Mex; 1996; 61(4):310-3. PubMed ID: 9072781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Campylobacter pylori and non-ulcer dyspepsia.
    Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
    Am J Gastroenterol; 1987 Nov; 82(11):1149-52. PubMed ID: 3673994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ulcer symptoms without demonstration of ulcer: causative therapy with demonstration of Helicobacter pylori].
    Kobler E; Müller B; Wüst W
    Schweiz Rundsch Med Prax; 1990 Mar; 79(13):398-9. PubMed ID: 2320815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical, endoscopic and histologic findings in 1,100 patients of whom 574 were colonized by Campylobacter pylori].
    Deltenre M; Nyst JF; Jonas C; Glupczynski Y; Deprez C; Burette A
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):89B-95B. PubMed ID: 2744327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Campylobacter pylori associated gastritis].
    Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunocytochemical identification of Campylobacter pylori in gastritis and correlation with culture.
    Barbosa AJ; Queiroz DM; Mendes EN; Rocha GA; Lima GF; Oliveira CA
    Arch Pathol Lab Med; 1988 May; 112(5):523-5. PubMed ID: 3282485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic erosive gastritis--a therapeutic approach with bismuth.
    Malfertheiner P; Stanescu A; Baczako K; Bode G; Ditschuneit H
    Scand J Gastroenterol Suppl; 1988; 142():87-92. PubMed ID: 3166538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of Campylobacter pylori infection].
    Börsch G
    Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic active surface-positive Campylobacter antrum gastritis-- morphological changes 1 year after treatment with bismuth].
    Sorf M; Krislo V; Gogora M
    Vnitr Lek; 1991; 37(9-10):768-71. PubMed ID: 1771809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
    Bravo LE; Realpe JL; Campo C; Mera R; Correa P
    Am J Gastroenterol; 1999 Sep; 94(9):2380-3. PubMed ID: 10483995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
    Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
    Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Campylobacter pylori: cause of gastritis and ulcer disease?].
    Gebbers JO; Altermatt HJ; Altorfer J
    Schweiz Med Wochenschr; 1988 Apr; 118(16):577-83. PubMed ID: 3289114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.
    Morgan D; Kraft W; Bender M; Pearson A
    Gastroenterology; 1988 Nov; 95(5):1178-84. PubMed ID: 3049213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.